|
Index of reports
> Cases resulting in life threatening events (8)
> Cases with Nephritis (4)
Below is the selection of adverse event reports related to Atacand (Candesartan Cilexetil) that includes cases resulting in life threatening events where reactions include nephritis.
Adverse event in male receiving Atacand (Candesartan Cilexetil)
Reported by a physician from Australia on 2007-03-07
Patient: male, weighing 87.0 kg (191.4 pounds)
Adverse reactions / side effects: Hepatitis Cholestatic, Hepatitis, Nephritis
Adverse event resulted in: life threatening event
Suspect drug(s):
Mobic
Administration route: Oral
Indication: Osteoarthritis
Start date: 2000-06-15
End date: 2006-08-15
Atacand
Administration route: Oral
Indication: Essential Hypertension
Start date: 2005-06-15
End date: 2006-08-15
Sildenafil Citrate
Administration route: Oral
Indication: Somatoform Disorder
Start date: 2003-06-15
End date: 2006-08-15
Atenolol
Administration route: Oral
Indication: Essential Hypertension
Start date: 2004-06-15
End date: 2006-08-15
Atorvastatin
Administration route: Oral
Indication: Metabolic Disorder
Start date: 2004-06-15
End date: 2006-08-15
Rabeprazole Sodium
Administration route: Oral
Indication: Oesophageal Disorder
Start date: 2005-07-15
End date: 2006-08-15
Adverse event in male receiving Atacand (Candesartan Cilexetil)
Reported by a physician from Australia on 2007-03-02
Patient: male, weighing 87.0 kg (191.4 pounds)
Adverse reactions / side effects: Hepatitis Cholestatic, Hepatitis, Nephritis
Adverse event resulted in: life threatening event
Suspect drug(s):
Mobic
Administration route: Oral
Indication: Osteoarthritis
Start date: 2000-06-15
End date: 2006-08-15
Atacand
Administration route: Oral
Indication: Somatoform Disorder
Start date: 2005-06-15
End date: 2006-08-15
Sildenafil Citrate
Administration route: Oral
Indication: Essential Hypertension
Start date: 2003-06-15
End date: 2006-08-15
Atenolol
Administration route: Oral
Indication: Metabolic Disorder
Start date: 2004-06-15
End date: 2006-08-15
Atorvastatin
Administration route: Oral
Indication: Essential Hypertension
Start date: 2004-06-15
End date: 2006-08-15
Rabeprazole Sodium
Administration route: Oral
Indication: Oesophageal Disorder
Start date: 2005-07-15
End date: 2006-08-15
Adverse event in male receiving Atacand (Candesartan Cilexetil)
Reported by a health professional (non-physician/pharmacist) from Australia on 2007-02-21
Patient: male
Adverse reactions / side effects: Hepatitis, Nephritis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Lipitor
Dosage: daily dose:10mg
Administration route: Oral
Indication: Metabolic Syndrome
Start date: 2004-06-15
End date: 2006-08-15
Atenolol
Dosage: daily dose:100mg
Administration route: Oral
Indication: Essential Hypertension
Start date: 2004-06-15
End date: 2006-08-15
Viagra
Dosage: daily dose:100mg-freq:prn
Administration route: Oral
Indication: Psychogenic Erectile Dysfunction
Start date: 2003-06-15
End date: 2006-08-15
Atacand
Dosage: daily dose:10mg
Administration route: Oral
Indication: Essential Hypertension
Start date: 2005-06-15
End date: 2006-08-15
Meloxicam
Dosage: daily dose:15mg
Administration route: Oral
Indication: Osteoarthritis
Start date: 2000-06-15
End date: 2006-08-15
Pariet
Dosage: daily dose:20mg
Administration route: Oral
Indication: Oesophageal Disorder
Start date: 2005-07-15
End date: 2006-08-15
Adverse event in male receiving Atacand (Candesartan Cilexetil)
Reported by a health professional (non-physician/pharmacist) from Australia on 2007-02-14
Patient: male
Adverse reactions / side effects: Hepatitis, Nephritis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Atenolol
Administration route: Oral
Indication: Essential Hypertension
Start date: 2004-06-15
End date: 2006-08-15
Atacand
Administration route: Oral
Indication: Essential Hypertension
Start date: 2005-06-15
End date: 2006-08-15
Lipitor
Administration route: Oral
Indication: Metabolic Disorder
Start date: 2004-06-15
End date: 2006-08-15
Meloxicam
Administration route: Oral
Indication: Osteoarthritis
Start date: 2000-06-15
End date: 2006-08-15
Pariet
Administration route: Oral
Indication: Oesophageal Disorder
Start date: 2005-07-15
End date: 2006-08-15
Viagra
Administration route: Oral
Indication: Somatoform Disorder
Start date: 2003-06-15
End date: 2006-08-15
|
